Fidelity Disruptive Medicine Fund (FMEDX) Stock
The fund primarily directs at least 80% of its total assets into companies that are leading advancements in the medical sector. Its core investments largely consist of equity instruments.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Peer Comparison
About Fidelity Disruptive Medicine Fund
The fund primarily directs at least 80% of its total assets into companies that are leading advancements in the medical sector. Its core investments largely consist of equity instruments. According to the Adviser, "disruptive medicine" companies encompass, but are not limited to, those engaged in fields such as robotic surgical procedures, gene therapy, genomic research, treatments for rare conditions, cutting-edge medical devices and apparatus, immunotherapy, digital healthcare platforms, and initiatives promoting consumer well-being. It is important to note that this fund operates as a non-diversified portfolio.
Fidelity Disruptive Medicine Fund is headquartered in US.
Fidelity Disruptive Medicine Fund (FMEDX) stock trades at $11.28 with a market capitalization of $43.22M. Over the past 52 weeks the stock has ranged between $10.96 and $11.60, and currently trades 2.8% below its 52-week high.